Your browser doesn't support javascript.
loading
Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma.
Oshima, Sonoko; Hagiwara, Akifumi; Raymond, Catalina; Wang, Chencai; Cho, Nicholas S; Lu, Jianwen; Eldred, Blaine S C; Nghiemphu, Phioanh L; Lai, Albert; Telesca, Donatello; Salamon, Noriko; Cloughesy, Timothy F; Ellingson, Benjamin M.
Afiliação
  • Oshima S; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California, Los Angeles, California, USA.
  • Hagiwara A; Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Raymond C; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California, Los Angeles, California, USA.
  • Wang C; Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Cho NS; Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan.
  • Lu J; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California, Los Angeles, California, USA.
  • Eldred BSC; Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Nghiemphu PL; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California, Los Angeles, California, USA.
  • Lai A; Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Telesca D; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California, Los Angeles, California, USA.
  • Salamon N; Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Cloughesy TF; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, California, USA.
  • Ellingson BM; Medical Scientist Training Program, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Neurooncol Adv ; 5(1): vdad084, 2023.
Article em En | MEDLINE | ID: mdl-37554221
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos